UNC Lineberger’s Ethan Basch, MD, MSc, professor in the UNC School of Medicine Division of Hematology/Oncology and director of the UNC Lineberger Cancer Outcomes Research Program, was corresponding author of a study designed to assess the feasibility and resource requirements associated with implementing the National Cancer Institute’s Patient-Reported Outcomes Common Terminology Criteria for Adverse Events in a multi-center trial.
For the study, 500 patients with locally advanced rectal cancer who were enrolled in an NCI-sponsored trial were asked to report 30 PRO-CTCAE items weekly from home during pre-operative therapy, and then every six months after surgery.
The researchers reported that gathering patient-reported outcomes in a multi-center trial is feasible, and they saw high patient compliance and low site administration requirements. To read the full study, click here.